121 related articles for article (PubMed ID: 10530930)
21. Relationship between progesterone receptor binding and progestin biological activity.
Spilman CH; Wilks JW; Campbell JA
J Steroid Biochem; 1985 Mar; 22(3):289-92. PubMed ID: 3921767
[TBL] [Abstract][Full Text] [Related]
22. Characterization of rat hypothalamic progestin binding by spheroidal hydroxylapatite chromatography.
Thrower S; Lim L
Biochem J; 1980 Jan; 186(1):295-300. PubMed ID: 7370015
[TBL] [Abstract][Full Text] [Related]
23. Pyridine-tert-nitrogen-phenol ligands: N,N,O-Type tripodal chelates for the [M(CO)3]+ core (M = Re, Tc).
Lim NC; Ewart CB; Bowen ML; Ferreira CL; Barta CA; Adam MJ; Orvig C
Inorg Chem; 2008 Feb; 47(4):1337-45. PubMed ID: 18189350
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and binding affinities of Re(I) and (99m)Tc(I)-containing 16alpha-substituted estradiol complexes: Models for potential breast cancer imaging agents.
Huang L; Zhu H; Zhang Y; Xu X; Cui W; Yang G; Shen YM
Steroids; 2010 Dec; 75(12):905-11. PubMed ID: 20493897
[TBL] [Abstract][Full Text] [Related]
25. Progestin receptors in human uterine cytosol.
Kasid A; Laumas KR
Mol Cell Endocrinol; 1980 Aug; 19(2):131-42. PubMed ID: 7409303
[TBL] [Abstract][Full Text] [Related]
26. Binding activity of 5alpha-reduced gestagens to the progestin receptor from African elephant (Loxodonta africana).
Meyer HH; Jewgenow K; Hodges JK
Gen Comp Endocrinol; 1997 Feb; 105(2):164-7. PubMed ID: 9038248
[TBL] [Abstract][Full Text] [Related]
27. Excited-state characteristics of tetracyanidonitridorhenium(V) and -technetium(V) complexes with N-heteroaromatic ligands.
Ikeda H; Ito A; Sakuda E; Kitamura N; Takayama T; Sekine T; Shinohara A; Yoshimura T
Inorg Chem; 2013 Jun; 52(11):6319-27. PubMed ID: 23679193
[TBL] [Abstract][Full Text] [Related]
28. Novel estradiol based metal complexes of Tc-99m.
Neto C; Oliveira MC; Gano L; Marques F; Thiemann T; Santos I
J Inorg Biochem; 2012 Jun; 111():1-9. PubMed ID: 22469776
[TBL] [Abstract][Full Text] [Related]
29. fac-Re(CO)3L complexes containing tridentate monoanionic ligands (L-) with a seldom-studied sulfonamido group as one terminal ligating group.
Christoforou AM; Fronczek FR; Marzilli PA; Marzilli LG
Inorg Chem; 2007 Aug; 46(17):6942-9. PubMed ID: 17655222
[TBL] [Abstract][Full Text] [Related]
30. Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy.
Cunha S; Gano L; Morais GR; Thiemann T; Oliveira MC
J Steroid Biochem Mol Biol; 2013 Sep; 137():223-41. PubMed ID: 23669457
[TBL] [Abstract][Full Text] [Related]
31. Effects of progestins on the progesterone receptor in guinea pig uterus.
Saffran J; Loeser BK; Faber LE
Adv Exp Med Biol; 1979; 117():223-39. PubMed ID: 474278
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological characterization of novel 2-quinolinecarboxamide ligands of the peripheral benzodiazepine receptors bearing technetium-99m or rhenium.
Cappelli A; Mancini A; Sudati F; Valenti S; Anzini M; Belloli S; Moresco RM; Matarrese M; Vaghi M; Fabro A; Fazio F; Vomero S
Bioconjug Chem; 2008 Jun; 19(6):1143-53. PubMed ID: 18510350
[TBL] [Abstract][Full Text] [Related]
33. Ligands for the estrogen receptor, containing cyclopentadienyltricarbonylrhenium units.
Spradau TW; Katzenellenbogen JA
Bioorg Med Chem Lett; 1998 Nov; 8(22):3235-40. PubMed ID: 9873709
[TBL] [Abstract][Full Text] [Related]
34. Trithiacyclononane as a ligand for potential technetium and rhenium radiopharmaceuticals: synthesis of [M(9S3)(SC2H4SC2H4S)][BF4] (M = 99Tc, Re, 188Re) via C-S bond cleavage.
Mullen GE; Blower PJ; Price DJ; Powell AK; Howard MJ; Went MJ
Inorg Chem; 2000 Sep; 39(18):4093-8. PubMed ID: 11198864
[TBL] [Abstract][Full Text] [Related]
35. Mixed-ligand rhenium-188 complexes with tetradentate/monodentate NS3/P ('4 + 1') coordination: relation of structure with antioxidation stability.
Schiller E; Seifert S; Tisato F; Refosco F; Kraus W; Spies H; Pietzsch HJ
Bioconjug Chem; 2005; 16(3):634-43. PubMed ID: 15898732
[TBL] [Abstract][Full Text] [Related]
36. Long-chain rhenium and technetium glucosamine conjugates.
Bowen ML; Chen ZF; Roos AM; Misri R; Häfeli U; Adam MJ; Orvig C
Dalton Trans; 2009 Nov; (42):9228-36. PubMed ID: 20449200
[TBL] [Abstract][Full Text] [Related]
37. Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.
Mizutani T; Bhakta A; Kloosterboer HJ; Moudgil VK
J Steroid Biochem Mol Biol; 1992 Aug; 42(7):695-704. PubMed ID: 1504008
[TBL] [Abstract][Full Text] [Related]
38. Molecular properties and preclinical pharmacology of JNJ-1250132, a steroidal progesterone receptor modulator that inhibits binding of the receptor to DNA in vitro.
Allan GF; Palmer E; Musto A; Lai MT; Clancy J; Palmer S
Steroids; 2006 Jul; 71(7):578-84. PubMed ID: 16597452
[TBL] [Abstract][Full Text] [Related]
39. Rhenium and technetium complexes of thioamide derivatives of pyridylhydrazine that bind to amyloid-β plaques.
Fletcher SP; Noor A; Hickey JL; McLean CA; White JM; Donnelly PS
J Biol Inorg Chem; 2018 Oct; 23(7):1139-1151. PubMed ID: 29982869
[TBL] [Abstract][Full Text] [Related]
40. A new strategy for the preparation of peptide-targeted technetium and rhenium radiopharmaceuticals. The automated solid-phase synthesis, characterization, labeling, and screening of a peptide-ligand library targeted at the formyl peptide receptor.
Stephenson KA; Banerjee SR; Sogbein OO; Levadala MK; McFarlane N; Boreham DR; Maresca KP; Babich JW; Zubieta J; Valliant JF
Bioconjug Chem; 2005; 16(5):1189-95. PubMed ID: 16173797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
